youtube_live
Q3 2026 earnings • released • EPS beat +8,62% • Revenue beat +2,31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
102,14 USD
arrow_upward
+1,31%(+1,32) 1D
102,14 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 6-ноя., 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
99,00 USD
High
102,19 USD
Low
98,50 USD
Mkt. cap
58,87 млд
Avg. vol.
4,32 млн
Volume
5,11 млн
P/E ratio
57,91
52-wk high
104,16 USD
52-wk low
74,66 USD
EPS
1,76 USD
Beta
0,85
Shares outstanding
575,00 млн
No. of employees
16 миң
Open
99,00 USD
High
102,19 USD
Low
98,50 USD
Mkt. cap
58,87 млд
Avg. vol.
4,32 млн
Volume
5,11 млн
P/E ratio
57,91
52-wk high
104,16 USD
52-wk low
74,66 USD
EPS
1,76 USD
Beta
0,85
Shares outstanding
575,00 млн
No. of employees
16 миң
News stories
From web sources and news partners
News Corp
·
1 күн мурун
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Zacks
·
1 күн мурун
HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?
TradingView
·
1 күн мурун
Key facts: EW beats, lifts view; TAVR meets goals; stock hits 2022 high
Yahoo Finance
·
2 күн мурун
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 миң
Founded1958
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteedwards.com